BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36504120)

  • 1. Safety profile and long-term efficacy of very high-power short-duration (60-70 W) catheter ablation for atrial fibrillation: results of a large comparative analysis.
    Popa MA; Bourier F; Lengauer S; Krafft H; Bahlke F; Förschner LV; Dorfmeister S; Kathan S; Telishevska M; Englert F; Lennerz C; Reents T; Hessling G; Deisenhofer I; Kottmaier M
    Europace; 2023 Feb; 25(2):408-416. PubMed ID: 36504120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pulsed-field ablation versus very high power short duration-ablation for pulmonary vein isolation.
    Wörmann J; Schipper JH; Lüker J; van den Bruck JH; Filipovic K; Erlhöfer S; Pavel F; Scheurlen C; Dittrich S; Steven D; Sultan A
    J Cardiovasc Electrophysiol; 2023 Dec; 34(12):2417-2424. PubMed ID: 37846194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial.
    Reddy VY; Grimaldi M; De Potter T; Vijgen JM; Bulava A; Duytschaever MF; Martinek M; Natale A; Knecht S; Neuzil P; Pürerfellner H
    JACC Clin Electrophysiol; 2019 Jul; 5(7):778-786. PubMed ID: 31320006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of very high-power short-duration radiofrequency ablation for pulmonary vein isolation: a two-centre report with emphasis on silent oesophageal injury.
    Halbfass P; Wielandts JY; Knecht S; Le Polain de Waroux JB; Tavernier R; De Wilde V; Sonne K; Nentwich K; Ene E; Berkovitz A; Mueller J; Lehmkuhl L; Reichart A; Lüsebrink U; Duytschaever M; Deneke T
    Europace; 2022 Mar; 24(3):400-405. PubMed ID: 34757432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesion metrics and 12-month outcomes of very-high power short duration radiofrequency ablation (90W/4 s) under mild conscious sedation.
    Calvert P; Koniari I; Mills MT; Ashrafi R; Snowdon R; Gupta D; Luther V
    J Cardiovasc Electrophysiol; 2024 Jun; 35(6):1165-1173. PubMed ID: 38571287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute oesophageal safety and long-term follow-up of AI-guided high-power short-duration with 50 W for atrial fibrillation ablation.
    Müller J; Nentwich K; Berkovitz A; Ene E; Sonne K; Zhuravlev V; Chakarov I; Barth S; Waechter C; Behnes M; Halbfass P; Deneke T
    Europace; 2023 Apr; 25(4):1379-1391. PubMed ID: 36881791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of high-power short duration atrial fibrillation ablation in elderly patients.
    Müller J; Nentwich K; Berkovitz A; Ene E; Sonne K; Chakarov I; Barth S; Waechter C; Lüsebrink U; Behnes M; Akin I; Deneke T
    J Cardiovasc Electrophysiol; 2022 Jul; 33(7):1425-1434. PubMed ID: 35441414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of ablation-induced esophageal injury associated with high-power short duration temperature-controlled pulmonary vein isolation using a specialized open-irrigated ablation catheter: A retrospective single-center study.
    Piringer R; Deneke T; Foldyna B; Sonne K; Nentwich K; Ene E; Barth S; Lüsebrink U; Berkovitz A; Halbfass P
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):695-703. PubMed ID: 33442930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of multipolar pulmonary vein ablation catheter vs. irrigated radiofrequency ablation for paroxysmal atrial fibrillation: a randomized multicentre trial.
    McCready J; Chow AW; Lowe MD; Segal OR; Ahsan S; de Bono J; Dhaliwal M; Mfuko C; Ng A; Rowland ER; Bradley RJ; Paisey J; Roberts P; Morgan JM; Sandilands A; Yue A; Lambiase PD
    Europace; 2014 Aug; 16(8):1145-53. PubMed ID: 24843051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote-controlled magnetic pulmonary vein isolation using a new three-dimensional non-fluoroscopic navigation system: a single-centre prospective study.
    Da Costa A; Ben H'dech M; Romeyer-Bouchard C; Bisch L; Gate-Martinet A; Levallois M; Isaaz K
    Arch Cardiovasc Dis; 2013; 106(8-9):423-32. PubMed ID: 23906679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
    Kottmaier M; Popa M; Bourier F; Reents T; Cifuentes J; Semmler V; Telishevska M; Otgonbayar U; Koch-Büttner K; Lennerz C; Bartkowiak M; Kornmayer M; Rousseva E; Brkic A; Grebmer C; Kolb C; Hessling G; Deisenhofer I
    Europace; 2020 Mar; 22(3):388-393. PubMed ID: 31872249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with a novel, irrigated, flexible tip ablation catheter in atrial fibrillation ablation.
    Pezzulich B; Taralli S; Villata G; Sori P
    Minerva Cardioangiol; 2015 Apr; 63(2):99-103. PubMed ID: 25000123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo tissue temperatures during 90 W/4 sec-very high power-short-duration (vHPSD) ablation versus ablation index-guided 50 W-HPSD ablation: A porcine study.
    Otsuka N; Okumura Y; Kuorkawa S; Nagashima K; Wakamatsu Y; Hayashida S; Ohkubo K; Nakai T; Hao H; Takahashi R; Taniguchi Y
    J Cardiovasc Electrophysiol; 2023 Feb; 34(2):369-378. PubMed ID: 36527433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of two 50 W high power short duration approaches-Temperature- versus ablation index-guided radiofrequency ablation for atrial fibrillation.
    Guckel D; Bergau L; Braun M; El Hamriti M; Mörsdorf M; Fink T; Sciacca V; Khalaph M; Imnadze G; Sommer P; Sohns C
    J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2517-2527. PubMed ID: 36104929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety aspects of very high power very short duration atrial fibrillation ablation using a modified radiofrequency RF-generator: Single-center experience.
    Mueller J; Halbfass P; Sonne K; Nentwich K; Ene E; Berkovitz A; Lehmkuhl L; Barth S; Simu GR; Waechter C; Behnes M; Deneke T
    J Cardiovasc Electrophysiol; 2022 May; 33(5):920-927. PubMed ID: 35233883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very High-Power Short-Duration, Temperature-Controlled Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: The Prospective Multicenter Q-FFICIENCY Trial.
    Osorio J; Hussein AA; Delaughter MC; Monir G; Natale A; Dukkipati S; Oza S; Daoud E; Di Biase L; Mansour M; Fishel R; Valderrabano M; Ellenbogen K;
    JACC Clin Electrophysiol; 2023 Apr; 9(4):468-480. PubMed ID: 36752484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation of atrial fibrillation-50 W or 90 W?
    Mueller J; Nentwich K; Ene E; Berkovitz A; Sonne K; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Halbfass P; Deneke T
    J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2504-2513. PubMed ID: 36124396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation Using a Circular Multipolar Ablation Catheter: Safety and Efficacy Using Low-Power Settings.
    Burri H; Park CI; Poku N; Giraudet P; Stettler C; Zimmermann M
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):170-4. PubMed ID: 26456225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and predictors of stroke and silent cerebral embolism following very high-power short-duration atrial fibrillation ablation.
    Boga M; Suhai FI; Orbán G; Salló Z; Nagy KV; Szegedi L; Jokkel Z; Csőre J; Osztheimer I; Perge P; Gupta D; Merkely B; Gellér L; Szegedi N
    Europace; 2023 Nov; 25(11):. PubMed ID: 37931067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of atrial fibrillation with cryoballoon or duty-cycled radiofrequency pulmonary vein ablation catheter: a randomized controlled study comparing the clinical outcome and safety; the AF-COR study.
    Malmborg H; Lönnerholm S; Blomström P; Blomström-Lundqvist C
    Europace; 2013 Nov; 15(11):1567-73. PubMed ID: 23703361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.